Analysts' Actions: AXP, MS, BLK, USB, CHK

NEW YORK ( TheStreet) -- CHANGE IN RATINGS, EPS

Abbott Laboratories ( AB) numbers raised at Goldman. Shares of ABT now seen reaching $59. Estimates also increased, to match the company's new guidance. Neutral rating.

Financial firm Access National ( ANCX) is upgraded to buy at TheStreet Ratings.

Agrium ( AGM) upgraded at JP Morgan to Overweight. Agriculture fundamentals are robust.

American Express ( AXP) removed from Top Picks at Citigroup.Shares of AXP now seen reaching $58. Estimates also lowered on Europe softness. Maintain Buy rating.

American Express estimates cut at Goldman through 2013. Company is releasing fewer reserves. Buy rating and $56 price target.

Amphenol ( APH) estimates, target lowered at Citigroup.Shares of APH now seen reaching $51. Estimates also lowered as defense spending trends remain clouded due to Washington. Buy rating.

Amphenol estimates, target cut at Credit Suisse.Shares of APH now seen reaching $49. Estimates also reduced, given weaker end-market demand. Outperform rating.

Amphenol estimates, target lowered at UBS.Shares of APH now seen reaching $46. Estimates also lowered as 4Q outlook impacted by Telecom/IT Datacom. Neutral rating.

Apollo ( APOL) estimates, target increased at Citigroup.Shares of APOL now seen reaching $50. Estimates also raised on positive outlook and regulatory concerns waning. Neutral rating.

Apollo estimates, target raised at Credit Suisse. Shares of APOL now seen reaching $52. Estimates also increased, given higher growth in starts. Outperform rating.

BlackRock ( BLK) estimates increased at Citigroup through 2012. NAVs partially offset by lower ST flows. Maintain $180 price target and Buy rating.

BlackRock estimates, target reduced at Credit Suisse.Shares of BLK now seen reaching $194. Estimates also cut, given lower net flows. Outperform rating.

Celestica ( CLS) downgraded at Ticonderoga from Buy to Neutral. Slower end-market demand could hurt growth. Company is also highly leveraged to Research in Motion.

Cheesecake Factory ( CAKE) numbers cut at Credit Suisse.Shares of CAKE now seen reaching $30. Estimates also reduced, as the company is struggling to leverage higher sales. Neutral rating.

Chesapeake Energy rated new Buy at Sterne Agee.CHK was initiated with a Buy rating. $40 price target. Company is cutting debt and liquids business should drive growth.

Cognizant ( CTSH) downgraded at Goldman to Neutral. Valuation call.

Comerica ( CMA) estimates, target lowered at Credit Suisse.CMA estimates were cut through 2012. Company is generating lower fee income and seeing higher loss provisions. Neutral rating and new $31 price target.

CSX ( CSX) estimates, target reduced at Credit Suisse.Shares of CSX now seen reaching $28. Estimates also cut, given slower volume growth. Outperform rating.

CSX downgraded at Wells from Outperform to Market Perform. Estimates also cut, as the company is seeing lower volume growth than its peers.

Cubist Pharmaceuticals ( CBST) numbers boosted at Oppenheimer.Shares of CBST now seen reaching $46. Estimates also upped, given higher Cubicin sales. Outperform rating.

eBay ( EBAY) estimates lowered at UBS through 2012. Raised guidance, mostly in line with street. Maintain $45 price target and Buy rating.

E*Trade ( ETFC) estimates, target cut at BMO.Shares of ETFC now seen reaching $9. Estimates also reduced, as the company is realizing lower margins. Market Perform rating.

Eastman Chemical ( EMN) downgraded at JP Morgan from Overweight to Neutral. $40 price target. Petrochemical returns are falling.

Equifax ( EFX) downgraded at Goldman to Sell. Company will be hurt by lower credit growth and a weaker labor market.

Fiserv ( FISV) upgraded at Goldman to Buy. Company has strong recurring revenue and can expand its margins. $67 price target.

Freeport-McMoran ( FCX) numbers reduced at Goldman. FCX estimates were cut through 2013. Company is leveraged to lower copper prices. Buy rating and new $46 price target.

Freeport-McMoRan estimates, target lowered at UBS.Shares of FCX now seen reaching $52. Estimates also lowered on near term labor uncertainty. Maintain Buy rating.

JC Penney ( JCP) rated new Overweight at JP Morgan. $37 price target. Company is embarking on a potential, multi-year sales and margin turnaround.

Kohl's ( KSS) rated new Underweight at JP Morgan. $42 price target. Margins are peaking and the company has a mature store base.

LAM Research ( LRCX) estimates cut at UBS through 2013. Reflects more conservative near term outlook. Maintain $50 price target and Buy rating.

Linear Technology ( LLTC) estimates, target lowered at UBS.Shares of LLTC now seen reaching $33. Estimates also lowered as macro indicators point to bottoming fundamentals. Buy rating.

M&T Bank ( MTB) numbers reduced at Jefferies.MTB estimates were cut through 2012. Company is seeing higher costs and realizing lower fee income. Hold rating and new $76 price target.

Macy's ( M) rated new Overweight at JP Morgan.Coverage of M was started with an Overweight rating. $36 price target. Company has several potential catalysts for sales and margin growth.

Marvell Technology ( MRVL) estimates, target cut at UBS.Shares of MRVL now seen reaching $18. Estimates also lowered on Thai flood impact. Buy rating.

Mednax ( MD) upgraded at Deutsche from Hold to Buy. $76 price target. Pullback has created an attractive buying opportunity.

Monster Worldwide ( MWW) numbers lowered at Credit Suisse.Shares of MWW now seen reaching $18. Estimates also cut, given slower macro growth. Outperform rating.

Morgan Stanley ( MS) estimates increased Oppenheimer through 2012. Company has limited European exposure. Outperform rating and $27 price target.

Newfield Exploration ( NFX) estimates, target cut at UBS.Shares of NFX now seen reaching $50. Estimates also lowered as 3Q results miss expectations for a second consecutive quarter.

Nordstrom ( JWN) rated new Neutral at JP Morgan. $55 price target. Company is facing tougher near-term comparisons.

ON Semiconductor ( ONNN) estimates, target cut at UBS.Shares of ONNN now seen reaching $7. Estimates also lowered on significant impact from Thailand floods. Neutral rating.

Paychex ( PAYX) upgraded at Goldman to Neutral. Company has limited downside earnings potential and the stock sports a solid dividend yield.

PNC Financial Services Group ( PNC) estimates, target raised at Citigroup.Shares of PNC now seen reaching $54. Estimates also increased to reflect better than expected loan growth and expense control. Neutral rating.

Polycom ( PLCM) estimates, target cut at BMO.Shares of PLCM now seen reaching $26. Estimates also reduced, to match the company's new guidance. Outperform rating.

Polycom downgraded at Morgan Keegan from Outperform to Market Perform. Demand is being hurt by slower macro growth. $22 price target.

Polycom downgraded at Piper from Overweight to Neutral. $20 price target. Company is facing increased competition.

Riverbed Technology ( RVBD) estimates raised at UBS.RVBD estimates raised through 2012. Better than expected 3Q results. Maintain $28 price target and neutral rating.

Sohu.com ( SOHU) is downgraded to hold at TheStreet Ratings.

Solera ( SLH) downgraded at Goldman to Sell. Valuation call.

Sonoco Products ( SON) downgraded at Deutsche from Buy to Hold. $33 price target. Fundamentals appear to be weakening.

Stryker ( SYK) numbers adjusted at UBS.Shares of SYK now seen reaching $59. Estimates slightly raised as company is growing organic revs. Buy rating.

Tractor Supply ( TSCO) numbers upped at Oppenheimer.TSCO estimates were boosted through 2012. Company continues to generate solid sales growth. Perform rating and new $74 price target.

United Rentals ( URI) estimates raised at UBS through 2012 on a more robust demand outlook. Maintain $40 price target and Buy rating.

US Bancorp ( USB) numbers increased at BMO.USB estimates were raised through 2012. Company is seeing higher sales growth. Outperform rating and new $31 price target.

Waste Connections ( WCN) numbers cut at Goldman through 2013. Company is seeing lower volumes. Neutral rating and new $37 price target.

Wynn Resorts ( WYNN) numbers cut at Morgan Stanley. Shares of WYNN now seen reaching $148. Estimates also reduced, given decelerating growth in revenue from VIP customers in Macau. Equal-weight rating.

Wynn Resorts estimates raised at UBS through 2012. October tracking solidly in Macau with no credit issues. Maintain $164 price target and Buy rating.

Xilinx ( XLNX) estimates, target lowered at Jefferies.Shares of XLNX now seen reaching $32. Estimates also cut, to match the company's new guidance. Hold rating.

Related links:


This article was written by a staff member of TheStreet.

More from Stocks

Flashback Friday: Amazon, Chip Stocks, Memorial Day

Flashback Friday: Amazon, Chip Stocks, Memorial Day

Week Ahead: Wall Street Looks to Jobs Report as North Korea Meeting Less Certain

Week Ahead: Wall Street Looks to Jobs Report as North Korea Meeting Less Certain

Dow and S&P 500 Decline, Energy Shares Fall as U.S. Crude Oil Slides 4%

Dow and S&P 500 Decline, Energy Shares Fall as U.S. Crude Oil Slides 4%

Replay: Jim Cramer on the Markets, 10-Year Yield, Oil Prices and Foot Locker

Replay: Jim Cramer on the Markets, 10-Year Yield, Oil Prices and Foot Locker

UAW Officially Files Complaint on Tesla Thanks to CEO Elon Musk

UAW Officially Files Complaint on Tesla Thanks to CEO Elon Musk